Given the antiproliferative effect observed following mitochondrial folate metabolism inhibition in K562 cells and in vivo, we labelled CML CD34+ cells with a fluorescent tracer of cell division (CTV) and treated them with imatinib, SHIN1 or a combination of both. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.